Arkolith/Insider Trading/CRVO

CRVO Insider Trading

CervoMed Inc. · full profile →Last filing Jun 11, 2026
Net Buying · 180d
Open-Market Buys (180d)
$3.0M
1 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$3.0M
open market, 180d
Reporting Insiders
1
1 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

87 shown
DateInsiderRoleActionSharesPriceValue
Jun 11, 2026Boger Joshua SDirector, 10% OwnerBuy(P)955K——
Jun 11, 2026Boger Joshua SDirector, 10% OwnerBuy(P)955K$3.14$3.0M
Jun 11, 2026Boger Joshua SDirector, 10% OwnerBuy(P)955K——
Jun 8, 2026Zavrl FrankDirectorGrant(A)8K—$0
Jun 8, 2026Sabbagh MarwanDirectorGrant(A)8K—$0
Jun 8, 2026Quigley DavidDirectorGrant(A)8K—$0
Jun 8, 2026Hollingsworth Jane HDirectorGrant(A)8K—$0
Jun 8, 2026Gregoire SylvieDirector, 10% OwnerGrant(A)8K—$0
Jun 8, 2026Boger Joshua SDirector, 10% OwnerGrant(A)8K—$0
Jun 8, 2026Alam John JCEO & President, Director, 10% OwnerGrant(A)8K—$0
Jun 8, 2026Poulton Jeffrey V.DirectorGrant(A)8K—$0
Feb 11, 2026Alam John JCEO & President, Director, 10% OwnerGrant(A)75K—$0
Feb 11, 2026Blackburn KellyEVP, Clinical DevelopmentGrant(A)30K—$0
Feb 11, 2026De Rosch MarkEVP, RA and GA and PgMGrant(A)30K—$0
Feb 11, 2026Elder William RobertCFO, GC & SecretaryGrant(A)30K—$0
Feb 11, 2026Gregoire SylvieDirector, 10% OwnerGrant(A)75K—$0
Feb 11, 2026Winton MatthewChief Commercial and BusinessGrant(A)30K—$0
Nov 18, 2025Elder William RobertCFO, GC & SecretaryBuy(P)3K$8.32$21K
Nov 18, 2025Winton MatthewChief Commercial and BusinessBuy(P)2K$7.95$12K
Nov 17, 2025Alam John JCEO & President, Director, 10% OwnerBuy(P)11K$8.46$91K
Nov 17, 2025Alam John JCEO & President, Director, 10% OwnerBuy(P)11K$8.46$91K
Nov 17, 2025Elder William RobertCFO, GC & SecretaryBuy(P)1K$8.45$8K
Nov 17, 2025Gregoire SylvieDirector, 10% OwnerBuy(P)11K$8.46$91K
Nov 17, 2025Gregoire SylvieDirector, 10% OwnerBuy(P)11K$8.46$91K
Nov 17, 2025Winton MatthewChief Commercial and BusinessBuy(P)4K$8.43$30K
Nov 14, 2025Winton MatthewChief Commercial and BusinessBuy(P)10K$7.57$76K
Nov 14, 2025Alam John JCEO & President, Director, 10% OwnerBuy(P)2K$7.57$13K
Nov 14, 2025Alam John JCEO & President, Director, 10% OwnerBuy(P)2K$7.55$13K
Nov 14, 2025Gregoire SylvieDirector, 10% OwnerBuy(P)2K$7.55$13K
Nov 14, 2025Gregoire SylvieDirector, 10% OwnerBuy(P)2K$7.57$13K
Nov 13, 2025Alam John JCEO & President, Director, 10% OwnerBuy(P)4K$7.51$33K
Nov 13, 2025Gregoire SylvieDirector, 10% OwnerBuy(P)4K$7.51$33K
Nov 12, 2025Alam John JCEO & President, Director, 10% OwnerBuy(P)6K$7.35$41K
Nov 12, 2025Elder William RobertCFO, GC & SecretaryBuy(P)4K$7.44$26K
Nov 12, 2025Gregoire SylvieDirector, 10% OwnerBuy(P)6K$7.35$41K
Oct 27, 2025Quigley DavidDirectorGrant(A)16K—$0
Oct 6, 2025Winton MatthewChief Commercial and BusinessGrant(A)75K—$0
Jun 23, 2025Gregoire SylvieDirector, 10% OwnerGrant(A)8K—$0
Jun 23, 2025Hollingsworth Jane HDirectorGrant(A)8K—$0
Jun 23, 2025Poulton Jeffrey V.DirectorGrant(A)8K—$0
Jun 23, 2025Sabbagh MarwanDirectorGrant(A)8K—$0
Jun 23, 2025Boger Joshua SDirector, 10% OwnerGrant(A)8K—$0
Jun 23, 2025Zavrl FrankDirectorGrant(A)8K—$0
Jun 23, 2025Alam John JCEO & President, Director, 10% OwnerGrant(A)8K—$0
May 14, 2025Elder William RobertCFO, GC & SecretaryBuy(P)4K$8.46$36K
Feb 4, 2025Alam John JCEO & President, Director, 10% OwnerGrant(A)60K—$0
Feb 4, 2025Blackburn KellySVP, Clinical DevelopmentGrant(A)27K—$0
Feb 4, 2025Cobuzzi Robert Joseph Jr.Chief Operating OfficerGrant(A)27K—$0
Feb 4, 2025Elder William RobertCFO & GCGrant(A)27K—$0
Feb 4, 2025Gregoire SylvieDirector, 10% OwnerGrant(A)60K—$0
Aug 27, 2024Elder William RobertCFO & GCBuy(P)1K$18.16$18K
Jun 14, 2024Zavrl FrankDirectorGrant(A)6K—$0
Jun 14, 2024Sabbagh MarwanDirectorGrant(A)6K—$0
Jun 14, 2024Poulton Jeffrey V.DirectorGrant(A)6K—$0
Jun 14, 2024Hollingsworth Jane HDirectorGrant(A)6K—$0
Jun 14, 2024Gregoire SylvieDirector, 10% OwnerGrant(A)6K—$0
Jun 14, 2024Boger Joshua SDirector, 10% OwnerGrant(A)6K—$0
Jun 14, 2024Alam John JCEO & President, Director, 10% OwnerGrant(A)6K—$0
Feb 26, 2024Boger Joshua SDirector, 10% OwnerOption exercise(X)496K——
Feb 26, 2024Boger Joshua SDirector, 10% OwnerSell(S)36——
Feb 26, 2024Boger Joshua SDirector, 10% OwnerOption exercise(X)496K——
Feb 12, 2024Boger Joshua SDirectorGrant(A)10K—$0
Jan 26, 2024Cobuzzi Robert Joseph Jr.Chief Operating OfficerGrant(A)56K—$0
Jan 26, 2024Gregoire SylvieDirector, 10% OwnerGrant(A)36K—$0
Jan 26, 2024Elder William RobertGC & SecretaryGrant(A)16K—$0
Jan 26, 2024Tanner John WilliamChief Financial OfficerGrant(A)16K—$0
Jan 26, 2024Blackburn KellySVP, Clinical DevelopmentGrant(A)16K—$0
Jan 26, 2024Alam John JCEO & President, Director, 10% OwnerGrant(A)36K—$0
Nov 20, 2023Tanner John WilliamChief Financial OfficerGrant(A)32K—$0
Nov 9, 2023Alam John JCEO & President, Director, 10% OwnerGift(G)13K—$0
Nov 9, 2023Gregoire SylvieDirector, 10% OwnerGift(G)10K—$0
Sep 15, 2023Blackburn KellyVP, Clinical DevelopmentGrant(A)16K—$0
Sep 15, 2023Davidson JillDirectorGrant(A)6K—$0
Sep 15, 2023Elder William RobertGC & SecretaryGrant(A)16K—$0
Sep 15, 2023Gregoire SylvieDirector, 10% OwnerGrant(A)36K—$0
Sep 15, 2023Gregoire SylvieDirector, 10% OwnerGrant(A)6K—$0
Sep 15, 2023Hollingsworth Jane HDirectorGrant(A)6K—$0
Sep 15, 2023Poulton Jeffrey V.DirectorGrant(A)6K—$0
Sep 15, 2023Sabbagh MarwanDirectorGrant(A)6K—$0
Sep 15, 2023Zavrl FrankDirectorGrant(A)6K—$0
Sep 15, 2023Alam John JCEO & President, Director, 10% OwnerGrant(A)6K—$0
Sep 15, 2023Alam John JCEO & President, Director, 10% OwnerGrant(A)36K—$0
Sep 15, 2023Tanner John WilliamChief Financial OfficerGrant(A)16K—$0
Sep 15, 2023Cobuzzi Robert Joseph Jr.Chief Operating OfficerGrant(A)16K—$0
Aug 31, 2023Hollingsworth Jane HDirectorDisposed to issuer(D)45——
Aug 31, 2023Hollingsworth Jane HDirectorOption exercise(M)122——
Aug 31, 2023Hollingsworth Jane HDirectorOption exercise(M)122—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).